# Analisi Completa: Controllo Meccanico, Contatto Cellulare e Organizzazione Tessutale

**Data:** 2026-01-31
**Confronti:** Progressione da EuE → OMA → CCOC/EnOC
**Compartimenti:** Epitelio, Stroma

---

## 1. Hippo Pathway (Meccanotrasduzione)

### 1.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **YAP1** | -0.02 | NS | **+0.79*** | 0.0007 | Effettore (oncogene) |
| **WWTR1/TAZ** | +0.003 | NS | **+0.63~** | 0.06 | Effettore (oncogene) |
| **STK4/MST1** | -0.04 | NS | **+0.77*** | 0.01 | Core kinase (soppressore) |
| STK3/MST2 | -0.55 | NS | -0.22 | 0.40 | Core kinase |
| LATS1 | +0.39 | NS | +0.29 | 0.23 | Core kinase (soppressore) |
| LATS2 | -0.48 | NS | +0.39 | 0.40 | Core kinase |
| SAV1 | -0.26 | NS | +0.10 | NS | Scaffold |
| MOB1A | +0.07 | NS | -0.01 | NS | Activator |
| MOB1B | +0.50 | NS | +0.20 | NS | Activator |
| NF2/Merlin | -0.07 | NS | -0.27 | 0.24 | Soppressore |
| **TEAD2** | +0.67 | NS | **-0.85*** | 0.004 | TF partner YAP |
| TEAD1 | -0.04 | NS | -0.50 | 0.22 | TF partner YAP |
| TEAD3 | +1.09~ | 0.41 | +0.24 | 0.56 | TF partner YAP |
| AMOTL2 | +0.29 | NS | +0.66 | 0.19 | YAP regulator |

**→ OMA Stroma: YAP1↑ ma anche STK4↑ (attivazione paradossa con feedback)**

### 1.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| YAP1 | -0.04 | NS | +0.31 | NS | Effettore |
| **WWTR1/TAZ** | **+2.47*** | 0.01 | +0.11 | NS | Effettore |
| **STK3/MST2** | **+3.27*** | 0.008 | **+1.13*** | 0.02 | Core kinase |
| STK4/MST1 | -0.43 | NS | -0.86 | 0.19 | Core kinase |
| LATS1 | -0.22 | NS | -0.60 | 0.22 | Core kinase |
| LATS2 | -0.25 | NS | -0.46 | NS | Core kinase |
| SAV1 | -0.35 | NS | -0.55 | 0.14 | Scaffold |
| MOB1A | -0.77 | NS | **-0.75*** | 0.03 | Activator |
| MOB1B | +1.40 | 0.34 | **+0.75~** | 0.05 | Activator |
| NF2/Merlin | +0.22 | NS | +0.18 | NS | Soppressore |
| **AMOT** | **-3.88~** | 0.10 | **-3.32~** | 0.05 | YAP regulator |
| **AMOTL2** | **-3.81*** | 0.001 | **-4.51*** | 6e-08 | YAP regulator |

**→ CCOC: TAZ/WWTR1↑↑↑ nell'epitelio, AMOT/AMOTL2↓↓↓ (rimozione freni su YAP!)**

### 1.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| YAP1 | +0.05 | NS | +0.08 | NS | Effettore |
| WWTR1/TAZ | -0.07 | NS | +0.02 | NS | Effettore |
| STK3/MST2 | +2.20 | 0.11 | +0.48 | NS | Core kinase |
| STK4/MST1 | +0.21 | NS | -0.06 | NS | Core kinase |
| **AMOTL2** | -0.64 | NS | **-2.69*** | 0.002 | YAP regulator |
| **AMOT** | +1.09 | NS | **-1.54~** | 0.13 | YAP regulator |
| **AMOTL1** | -0.79 | NS | **+0.66~** | 0.10 | YAP regulator |
| MOB1B | -1.25 | 0.11 | **+0.92*** | 0.006 | Activator |

**→ EnOC: Meno alterato vs CCOC, ma AMOTL2↓ nello stroma**

### 1.4 Hippo Summary

| Componente | OMA | CCOC | EnOC |
|------------|-----|------|------|
| **YAP1** | ↑ stroma | = | = |
| **WWTR1/TAZ** | ↑ stroma | **↑↑↑ epitelio** | = |
| **AMOT/AMOTL2** | = | **↓↓↓** (freni rimossi) | ↓ stroma |
| **MOB1A** | = | **↓** | = |

---

## 2. Adesione Cellulare: Giunzioni Aderenti

### 2.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **CDH1** | -0.37 | NS | **-2.82*** | 0.03 | E-caderina |
| **CDH2** | **+3.85~** | 0.18 | +0.01 | NS | N-caderina |
| **CDH3** | **+4.70*** | 0.001 | **+2.72*** | 0.0008 | P-caderina |
| **CTNNB1** | **+0.78~** | 0.17 | +0.44 | 0.27 | β-catenina |
| CTNNA1 | -0.34 | NS | +0.01 | NS | α-catenina |
| CTNND1 | -0.49 | NS | -0.37 | 0.28 | p120-catenina |
| JUP | **-1.77~** | 0.11 | -0.26 | NS | γ-catenina/plakoglobin |

**→ OMA: Switch CDH1→CDH2/CDH3 (EMT signature!), β-catenina UP**

### 2.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| CDH1 | -0.05 | NS | **+2.65*** | 0.01 | E-caderina |
| **CDH2** | **-5.27*** | 0.0005 | **-1.22~** | 0.10 | N-caderina |
| CDH3 | -0.70 | NS | **-1.65~** | 0.06 | P-caderina |
| **CTNNB1** | -1.24 | 0.34 | -0.38 | 0.38 | β-catenina |
| CTNNA1 | +0.49 | NS | **+0.40~** | 0.14 | α-catenina |
| CTNND1 | -0.06 | NS | -0.25 | NS | p120-catenina |
| JUP | +0.86 | NS | -0.13 | NS | γ-catenina |

**→ CCOC: Reversione EMT! CDH2↓↓↓, CDH1↑ nello stroma (MET)**

### 2.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **CDH1** | -1.43 | 0.07 | **+2.12~** | 0.22 | E-caderina |
| CDH2 | -3.35 | 0.10 | -0.52 | NS | N-caderina |
| CDH3 | -0.05 | NS | **-1.33~** | 0.24 | P-caderina |
| CTNNB1 | +0.006 | NS | -0.54 | 0.37 | β-catenina |
| CTNNA1 | +0.04 | NS | **+0.53~** | 0.16 | α-catenina |
| JUP | +0.65 | NS | +0.13 | NS | γ-catenina |

**→ EnOC: Pattern MET simile a CCOC ma meno pronunciato**

---

## 3. Adesione Cellulare: Tight Junctions e Claudine

### 3.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **CLDN3** | **-2.04*** | 0.09 | **-8.27*** | 9e-13 | Claudina-3 |
| **CLDN4** | **-3.18*** | 0.001 | **-7.91*** | 3e-14 | Claudina-4 |
| **CLDN7** | -0.61 | NS | **-3.56*** | 0.002 | Claudina-7 |
| CLDN1 | +2.69 | 0.54 | +0.91 | 0.24 | Claudina-1 |
| TJP1 | -0.67 | NS | -0.17 | NS | ZO-1 |
| TJP2 | +1.76 | 0.69 | +0.43 | NS | ZO-2 |
| **OCLN** | **-1.35~** | 0.36 | -1.08 | 0.31 | Occludina |

**→ OMA: CLDN3/4/7↓↓↓ (perdita tight junctions) - MASSIVO nello stroma**

### 3.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **CLDN4** | **+1.87~** | 0.07 | **+5.61*** | 4e-08 | Claudina-4 |
| **CLDN7** | **-5.09*** | 1.6e-07 | -2.15 | NA | Claudina-7 |
| CLDN3 | +0.46 | NS | **+5.52*** | 2.5e-05 | Claudina-3 |
| CLDN1 | **-2.83~** | 0.05 | +0.82 | 0.23 | Claudina-1 |
| TJP1 | -0.51 | NS | +0.19 | NS | ZO-1 |
| OCLN | -1.07 | NS | **-1.92~** | 0.19 | Occludina |

**→ CCOC: CLDN4↑↑↑ (marcatore CCOC!), ma CLDN7↓↓↓ nell'epitelio**

### 3.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **CLDN1** | **-5.02*** | 0.08 | **+2.58*** | 0.005 | Claudina-1 |
| **CLDN4** | +1.57 | 0.54 | **+5.01** | NA | Claudina-4 |
| CLDN3 | -0.48 | NS | +4.37~ | 0.10 | Claudina-3 |
| CLDN7 | -0.98 | NS | +1.55 | NA | Claudina-7 |
| OCLN | -1.87~ | 0.38 | **-2.05~** | 0.18 | Occludina |

**→ EnOC: CLDN1↓ epitelio ma ↑ stroma (divergenza compartimentale)**

---

## 4. Adesione Cellulare: Desmosomi

### 4.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **DSC3** | **+10.78*** | 2.1e-05 | +3.10 | NA | Desmocollina-3 |
| DSP | -0.90 | NS | **-2.63*** | 0.008 | Desmoplachina |
| DSG2 | -0.13 | NS | **+1.76*** | 0.03 | Desmogleina-2 |
| DSG3 | +3.51 | 0.09 | +0.35 | NS | Desmogleina-3 |
| PKP2 | +0.51 | NS | **+1.77*** | 0.007 | Placofilina-2 |
| PKP3 | -0.39 | NS | **-4.22*** | 0.006 | Placofilina-3 |

**→ OMA: DSC3↑↑↑ nell'epitelio, rimodellamento desmosomi**

### 4.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **DSC3** | **-4.45*** | 0.02 | +0.48 | NS | Desmocollina-3 |
| DSP | +1.16 | 0.36 | **+2.56*** | 0.003 | Desmoplachina |
| DSG2 | -0.22 | NS | -0.54 | NS | Desmogleina-2 |
| **PKP2** | **-2.56~** | 0.05 | +0.16 | NS | Placofilina-2 |

**→ CCOC: DSC3↓↓↓ (reversione pattern OMA), DSP↑ stroma**

### 4.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| DSC3 | -1.56 | NS | -1.52 | NA | Desmocollina-3 |
| DSP | +0.91 | NS | **+2.83*** | 0.03 | Desmoplachina |
| DSC2 | +1.52 | NS | +1.46 | NA | Desmocollina-2 |
| **PKP2** | +0.17 | NS | **-1.55*** | 0.04 | Placofilina-2 |

**→ EnOC: DSP↑ stroma (rafforzamento desmosomi stromali)**

---

## 5. Adesioni Focali e Integrine

### 5.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **ITGA6** | **-2.71*** | 0.04 | **-2.53*** | 4e-05 | α6-integrina |
| **ITGB4** | +0.55 | NS | **-2.19*** | 0.02 | β4-integrina |
| **ITGB6** | +1.87 | 0.57 | **-5.90*** | 0.003 | β6-integrina |
| ITGA3 | +1.61 | 0.14 | +0.97 | 0.16 | α3-integrina |
| ITGB5 | **+1.31*** | 0.10 | **+0.86~** | 0.06 | β5-integrina |
| ITGAV | +0.09 | NS | +0.12 | NS | αV-integrina |
| ITGB1 | +0.15 | NS | +0.17 | NS | β1-integrina |
| PTK2/FAK | -0.32 | NS | +0.09 | NS | Focal adhesion kinase |
| VCL | -0.16 | NS | -0.39 | 0.32 | Vinculina |
| PXN | -0.70 | NS | -0.47 | 0.09 | Paxillina |
| SRC | -1.34 | NS | -0.26 | NS | SRC kinase |

**→ OMA: ITGA6/B4/B6↓↓↓ (perdita ancoraggio membrana basale)**

### 5.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **PTK2/FAK** | **+2.82*** | 0.02 | **+1.73*** | 7e-06 | Focal adhesion kinase |
| **VCL** | +1.54 | 0.20 | **+0.88*** | 0.04 | Vinculina |
| **PXN** | +0.88 | NS | **+10.01*** | 3e-09 | Paxillina |
| **ITGA2** | +1.23 | NS | **+2.58*** | 1.2e-06 | α2-integrina |
| **ITGA6** | +1.64 | 0.35 | **+1.22*** | 0.03 | α6-integrina |
| ITGA1 | -1.78 | 0.36 | +0.89 | 0.13 | α1-integrina |
| ITGB4 | **-2.19~** | 0.17 | +1.40 | 0.22 | β4-integrina |
| ITGB1 | -0.80 | NS | **-1.04~** | 0.05 | β1-integrina |
| SRC | +0.41 | NS | **-1.36~** | 0.08 | SRC kinase |

**→ CCOC: FAK/VCL/PXN↑↑↑ (adesioni focali RINFORZATE nello stroma)**

### 5.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **PTK2/FAK** | +1.65 | 0.23 | **+1.41*** | 0.008 | Focal adhesion kinase |
| **ITGA6** | +1.33 | 0.23 | **+2.16*** | 0.01 | α6-integrina |
| **ITGA1** | +1.02 | NA | **+1.50*** | 0.03 | α1-integrina |
| **ITGA4** | +1.75 | NS | **+2.17*** | 0.04 | α4-integrina |
| **ITGA2** | +0.08 | NS | **+3.57** | NA | α2-integrina |
| ITGB4 | -1.33 | 0.58 | +1.55 | 0.26 | β4-integrina |
| VCL | -0.11 | NS | +0.20 | NS | Vinculina |
| PXN | +1.14 | 0.21 | +0.39 | NS | Paxillina |

**→ EnOC: FAK↑, ITGA1/2/4/6↑ nello stroma (rimodellamento integrine)**

---

## 6. Rho GTPases e Citoscheletro

### 6.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **ACTA2** | **+4.05*** | 6.5e-05 | +0.68 | NS | α-SMA |
| **MYH10** | **+2.56*** | 0.003 | **+1.00*** | 0.003 | Miosina II |
| ROCK1 | **+0.81~** | 0.07 | **+0.44~** | 0.14 | Rho kinase |
| ROCK2 | +0.33 | NS | -0.13 | NS | Rho kinase |
| RHOA | +0.01 | NS | -0.10 | NS | Rho GTPase |
| RAC1 | -0.29 | NS | -0.62 | 0.29 | Rac GTPase |
| CDC42 | -0.41 | NS | **-0.32~** | 0.18 | Cdc42 GTPase |

**→ OMA: ACTA2/MYH10↑↑↑ nell'epitelio (acquisizione fenotipo contrattile/miofibroblastico)**

### 6.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **ACTA2** | **-3.55*** | 0.004 | -0.10 | NS | α-SMA |
| MYH10 | -1.36 | 0.42 | +0.32 | NS | Miosina II |
| MYH9 | -0.29 | NS | **+0.73*** | 0.01 | Miosina IIA |
| ROCK1 | -0.72 | NS | -0.29 | NS | Rho kinase |
| RHOA | -0.45 | NS | **-0.55~** | 0.07 | Rho GTPase |
| **CDC42** | -1.04 | 0.16 | **-1.46*** | 3e-06 | Cdc42 GTPase |

**→ CCOC: ACTA2↓↓↓ (perdita fenotipo miofibroblastico), CDC42↓↓↓ stroma**

### 6.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **ACTA2** | **-5.15*** | 0.0008 | -0.63 | NS | α-SMA |
| MYH10 | -0.49 | NS | -0.40 | NS | Miosina II |
| RHOA | -0.14 | NS | +0.38 | 0.35 | Rho GTPase |
| RAC1 | +0.28 | NS | +1.00 | 0.35 | Rac GTPase |
| CDC42 | -1.45 | 0.05 | -0.48 | NS | Cdc42 GTPase |

**→ EnOC: ACTA2↓↓↓ nell'epitelio (come CCOC)**

---

## 7. Polarità Cellulare

### 7.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **CRB3** | **-1.90*** | 0.02 | **-3.86*** | 0.0005 | Crumbs apical |
| **PARD6B** | -0.42 | NS | **-1.71~** | 0.08 | Par6 apical |
| PARD3 | -0.91 | NS | +0.20 | NS | Par3 apical |
| SCRIB | -1.46 | 0.51 | +0.04 | NS | Scribble basolateral |
| DLG1 | +0.38 | NS | -0.26 | 0.41 | Discs Large |
| LLGL2 | **-1.31~** | 0.35 | -0.79 | 0.47 | Lethal giant larvae |
| VANGL2 | +1.31 | 0.82 | **-0.74*** | 0.02 | Planar cell polarity |

**→ OMA: CRB3↓↓↓ (perdita polarità apicale), VANGL2↓ stroma**

### 7.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **PARD3** | **+3.85*** | 0.002 | **+3.26*** | 1.3e-10 | Par3 apical |
| **LLGL2** | +1.93 | 0.23 | **+2.15*** | 0.003 | Lethal giant larvae |
| **DLG1** | +0.71 | NS | **+1.62*** | 3e-09 | Discs Large |
| CRB3 | +0.74 | NS | +0.89 | NA | Crumbs |
| PARD6B | -1.19 | NS | +1.45 | 0.23 | Par6 |
| SCRIB | +0.88 | NS | **-1.26~** | 0.14 | Scribble |
| VANGL2 | -3.89~ | 0.04 | -1.05 | 0.27 | Planar cell polarity |

**→ CCOC: PARD3/DLG1/LLGL2↑↑↑ (ristabilimento complessi polarity)**

### 7.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **PARD3** | **+3.07~** | 0.03 | **+1.86*** | 1.1e-11 | Par3 apical |
| **CRB3** | +1.43 | 0.17 | **+3.35*** | 0.04 | Crumbs |
| **DLG1** | +1.02 | 0.36 | **+1.15*** | 0.01 | Discs Large |
| LLGL2 | +1.78 | 0.87 | **+1.49~** | 0.18 | Lethal giant larvae |
| SCRIB | +1.75~ | 0.05 | +0.05 | NS | Scribble |
| VANGL2 | -0.15 | NS | -0.72 | 0.22 | Planar cell polarity |

**→ EnOC: PARD3/CRB3/DLG1↑ (ristabilimento polarità come CCOC)**

---

## 8. Matrice Extracellulare (ECM)

### 8.1 OMA vs EuE

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **FN1** | **+5.60*** | 5.4e-20 | **+1.10*** | 0.07 | Fibronectina |
| **SPARC** | **+3.24*** | 0.01 | +0.15 | NS | Osteonectina |
| **THBS2** | **+4.16~** | 0.09 | **+1.20~** | 0.11 | Trombospondina-2 |
| **COL1A1** | **+1.85~** | 0.16 | +0.51 | 0.42 | Collagene I |
| COL1A2 | +0.14 | NS | **+1.27*** | 0.03 | Collagene I |
| **LAMA1** | -3.30 | 0.26 | **+3.55*** | 1e-15 | Laminina α1 |
| LAMB1 | +1.37 | 0.53 | +0.23 | NS | Laminina β1 |
| COL4A1 | +0.44 | NS | **-1.21*** | 0.01 | Collagene IV |
| COL4A2 | +0.14 | NS | **-1.30*** | 0.002 | Collagene IV |

**→ OMA: FN1↑↑↑/SPARC↑ (ECM fibrosa), COL4A1/A2↓ stroma (perdita membrana basale)**

### 8.2 CCOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **SPARC** | **-4.74*** | 8e-08 | +0.34 | NS | Osteonectina |
| **THBS1** | **-4.32*** | 2.9e-06 | -0.53 | NS | Trombospondina-1 |
| **THBS2** | **-3.22*** | 0.05 | +1.06 | 0.20 | Trombospondina-2 |
| **COL1A1** | **-2.90*** | 0.007 | +0.04 | NS | Collagene I |
| **COL1A2** | **-2.72*** | 0.03 | +0.86 | 0.25 | Collagene I |
| **FN1** | -1.92 | 0.10 | **+1.83*** | 0.02 | Fibronectina |
| **LAMB1** | **+3.07*** | 0.03 | +1.15 | 0.17 | Laminina β1 |
| **LAMA1** | +6.02~ | 0.13 | **+1.65~** | 0.04 | Laminina α1 |
| **LAMC1** | +1.88~ | 0.13 | +0.36 | NS | Laminina γ1 |
| COL4A1 | +1.33 | 0.31 | +0.94 | 0.17 | Collagene IV |
| COL4A2 | +1.39 | 0.29 | +0.56 | 0.34 | Collagene IV |

**→ CCOC: ECM "antifibrosa" nell'epitelio (SPARC↓, COL1↓, THBS1/2↓), LAMININA↑**

### 8.3 EnOC vs OMA

| Gene | Epithelium log2FC | p-adj | Stroma log2FC | p-adj | Funzione |
|------|-------------------|-------|---------------|-------|----------|
| **SPARC** | **-3.93~** | 0.18 | +0.26 | NS | Osteonectina |
| **THBS1** | -2.92 | 0.80 | **-1.30~** | 0.06 | Trombospondina-1 |
| **THBS2** | **-5.87*** | 0.48 | **-1.53~** | 0.05 | Trombospondina-2 |
| **FN1** | **-3.80~** | 0.54 | -0.71 | NS | Fibronectina |
| **COL4A1** | -2.65~ | 0.04 | **+1.62*** | 0.03 | Collagene IV |
| **COL4A2** | -1.98 | 0.12 | **+1.03*** | 0.11 | Collagene IV |
| LAMA1 | +5.31 | 0.14 | +1.46~ | 0.09 | Laminina α1 |
| LAMB3 | -1.93 | 0.35 | **+1.55~** | 0.13 | Laminina β3 |

**→ EnOC: FN1↓, THBS↓ nell'epitelio; COL4↑ nello stroma (ricostruzione membrana basale)**

---

## 9. Modello Integrato: Progressione Meccanica

### 9.1 OMA vs Endometrio Eutopico

```
ENDOMETRIO EUTOPICO
├── Polarità: CRB3+ (apical complex)
├── Adesione: CDH1+ (E-cad), CLDN3/4/7+ (tight junctions)
├── Integrine: ITGA6/B4/B6 (ancoraggio basale)
├── ECM: COL4 (membrana basale), ECM moderata
└── Citoscheletro: ACTA2 low

         ↓ Trasformazione OMA ↓

ENDOMETRIOMA (OMA)
├── Polarità: CRB3↓↓↓ (perdita)
├── Adesione: CDH1↓→CDH2/3↑ (EMT switch!)
│            CLDN3/4/7↓↓↓ (tight junctions perse)
├── Integrine: ITGA6/B4/B6↓↓↓ (distacco basale)
├── ECM: FN1↑↑↑, SPARC↑, COL1↑
│        COL4↓ (perdita membrana basale)
├── Citoscheletro: ACTA2↑↑↑, MYH10↑ (miofibroblastico)
├── Hippo: YAP1↑ stroma
└── Fenotipo: EMT + FIBROSI
```

### 9.2 Trasformazione Tumorale (vs OMA)

```
CCOC (vs OMA)
├── Polarità: PARD3↑↑↑, DLG1↑↑, LLGL2↑ (RISTABILITA!)
├── Adesione: CDH2↓↓↓, CDH1↑ stroma (MET!)
│            CLDN4↑↑↑ (marcatore CCOC)
│            DSC3↓, DSP↑
├── Integrine: ITGA2↑, ITGA6↑ (nuova adesione)
├── Focal adhesion: FAK↑↑↑, PXN↑↑↑, VCL↑ (RINFORZATE)
├── ECM: SPARC↓↓↓, THBS↓↓↓, COL1↓↓
│        LAMININA↑↑↑ (ricostruzione basale)
├── Citoscheletro: ACTA2↓↓↓, CDC42↓↓
├── Hippo: TAZ/WWTR1↑↑↑, AMOT/L2↓↓↓ (freni rimossi)
└── Fenotipo: MET + EPITELIALIZZAZIONE + ADESIONE STROMALE

EnOC (vs OMA)
├── Polarità: PARD3↑, CRB3↑, DLG1↑ (ristabilita ma <CCOC)
├── Adesione: MET pattern (meno pronunciato)
│            CLDN1↓ epitelio / ↑ stroma
├── Integrine: ITGA1/2/4/6↑ stroma
├── Focal adhesion: FAK↑ (moderato)
├── ECM: THBS↓, COL4↑ stroma
├── Citoscheletro: ACTA2↓↓↓
├── Hippo: AMOTL2↓ stroma
└── Fenotipo: MET moderato + meno adesione focale
```

---

## 10. Insights Chiave

### 10.1 OMA = EMT + Perdita Polarità + Fibrosi

| Caratteristica | Stato |
|----------------|-------|
| E-caderina (CDH1) | ↓↓ |
| N-caderina (CDH2) | ↑↑ |
| Tight junctions (CLDN3/4/7) | ↓↓↓ |
| Polarità (CRB3) | ↓↓↓ |
| ECM fibrosa (FN1, COL1) | ↑↑↑ |
| α-SMA (ACTA2) | ↑↑↑ |

**→ Fenotipo "fibroblastoide" / miofibroblastico**

### 10.2 Tumori = MET + Ripristino Polarità

| Feature | CCOC | EnOC |
|---------|------|------|
| **MET (CDH1↑, CDH2↓)** | ✅ FORTE | ✅ Moderato |
| **Polarità (PARD3↑)** | ✅ +3.85*** | ✅ +3.07~ |
| **CLDN4** | ↑↑↑ | ↑ |
| **ACTA2** | ↓↓↓ | ↓↓↓ |
| **Focal adhesion** | ↑↑↑ (FAK, PXN) | ↑ (FAK) |

**I tumori REVERTONO l'EMT dell'OMA e ristabiliscono polarità epiteliale!**

### 10.3 Hippo Pathway: CCOC-Specifico

| Componente | CCOC | EnOC |
|------------|------|------|
| **TAZ/WWTR1** | **+2.47*** | NS |
| **AMOTL2** | **-4.51***  | -2.69* |
| **MOB1A** | **-0.75*** | NS |

**CCOC attiva specificamente TAZ e rimuove i freni AMOT → YAP/TAZ attivi**

### 10.4 Adesioni Focali: Driver Stromale in CCOC

| Gene | CCOC Stroma | EnOC Stroma |
|------|-------------|-------------|
| **PXN** | **+10.01***↑↑↑ | +0.39 |
| **PTK2/FAK** | **+1.73*** | +1.41* |
| **VCL** | +0.88* | +0.20 |
| **ITGA2** | **+2.58*** | +3.57 |

**CCOC ha massivo rinforzo adesioni focali stromali (PXN 10x!)**

---

## 11. Implicazioni Terapeutiche

| Target | CCOC Rationale | EnOC Rationale |
|--------|----------------|----------------|
| **Inibitori YAP/TAZ** (verteporfin) | TAZ +2.47***, AMOTL2↓ | AMOTL2↓ stroma |
| **Inibitori FAK** (defactinib) | FAK +1.73***, PXN +10*** | FAK +1.41* |
| **Anti-CLDN4** | CLDN4 +5.61*** | CLDN4↑ |
| **Anti-integrine α2** | ITGA2 +2.58*** | ITGA2↑↑ |

---

## 12. Limitazioni

1. **N=3 CCOC:** Risultati da interpretare con cautela
2. **EnOC epitelio:** Molti geni NS (basso n?)
3. **Pathway crosstalk:** Non catturato nell'analisi singolo-gene
4. **Proteina vs trascritto:** Localizzazione non valutata

---

*Analisi completata: 2026-01-31*
*Legenda: * p<0.05, *** p<0.001, ~ p<0.1, NS = non significativo, NA = padj non disponibile*
